Arena Pharmaceuticals Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | C | ALPS Medical Breakthroughs ETF | 0.43 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 0.24 | |
IWC | B | iShares Microcap ETF | 0.07 | |
IWO | B | iShares Russell 2000 Growth ETF | 0.02 | |
AVSC | B | Avantis U.S. Small Cap Equity ETF | 0.02 |
Compare ETFs
Related Industries:
Biotechnology
- Arena Pharmaceuticals
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company’s most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), etrasimod (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn’s disease. In 2016 the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles